Family Factor Home
Family Factor is a specialty care pharmacy offering a full line of factor replacement medications and auxiliary supplies, education, and support for patients with hemophilia and other bleeding disorders. Our pharmacy and nursing staffs work closely with patients, caregivers, and medical providers to deliver the highest quality of care and achieve the best possible outcomes. We are currently licensed in Alabama, Mississippi, Tennessee, Florida, Arkansas and Missouri. If you are interested in our services, please contact us.
promise to you
Our
Setting the Standards
Mission Statement
Family Factor's mission is to provide the highest quality of pharmacy services, medications, and medical care possible to patient and family, while realizing our responsibility to the community and society as a whole.
Family Factor is in accordance with all recommendations, in many cases exceeding expectations, regarding standards of service for pharmacy providers of clotting factor concentrates for home use to patients with bleeding disorders, which are outlined in the Medical and Scientific Advisory Council's (MASAC) Document #188. Additionally, Family Factor meets or exceeds all standards of care set forth by Alabama Medicaid. You can view a video, which is posted on Alabama Medicaid's website, outlining these standards here.
Know Your Diseases
The primary congenital bleeding disorders are hemophilia A and hemophilia B, which affect approximately 1 in 5,000 males and von Willebrand's Disease which affect an estimated 1 in 100 men and women.
For effective blood clotting, the body requires several plasma proteins called factors. People affected with hemophilia are either missing a particular factor that is essential to the clotting process or the factor is present but doesn't work. Without this active factor, bleeding into muscles, joints and internal organs can occur, often without any noticeable trauma.
One of the most serious and costly complications of hemophilia, unfortunately also happens to be one of the most common. This complication, which occurs in as many as 30 percent of patients with hemophilia, is the development of an antibody – an inhibitor – to the product being used to treat or prevent bleeding. Oftentimes, the presence of an inhibitor requires the use of special factor replacement medications called Bypassing Agents.
The treatment of a bleeding episode can vary depending on the severity of the disease and the presence/absence of an inhibitor; for most patients, however, it involves replacement of the missing protein through the intravenous administration of factor concentrate.
Click the following links for a list of factor replacement products currently available:
family factor ©2006 l factor products l nursing l education l advocacy
 | ||||||
factor products | nursing | education | advocacy
